Starting Your Journey: What’s the Lowest Dose of Semaglutide?

Last reviewed: May 15, 2026 Last updated: May 15, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Beginning a GLP-1 weight loss program requires patience and precision. PlexusDx customizes your semaglutide starting dose and escalation schedule based on your health profile, helping you achieve results while maintaining comfort and safety throughout the treatment process.

Understanding Semaglutide as a Weight Management Solution

Semaglutide belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed to manage type 2 diabetes. Clinical research has demonstrated its remarkable effectiveness for weight management in individuals with obesity or overweight conditions who struggle with diet and exercise alone.

The STEP clinical trials showed that semaglutide users experienced weight reductions of 15-22% over 68 weeks—substantially higher than results achieved through lifestyle modifications alone. This medication works by affecting areas of the brain that regulate hunger and fullness, naturally reducing food intake and cravings without requiring willpower-dependent restriction.

Unlike crash diets or stimulant-based weight loss products, semaglutide creates sustainable changes in appetite regulation and metabolic function. PlexusDx offers compounded semaglutide injections starting at $179 per month, making this proven therapy accessible without insurance requirements or membership fees.

What Is the Lowest Starting Dose of Semaglutide?

The lowest effective starting dose of semaglutide for weight management is 0.25 milligrams, administered as a weekly subcutaneous injection. This microdose allows your body to adapt to the medication while minimizing initial side effects that some patients experience when beginning GLP-1 therapy.

PlexusDx uses evidence-based protocols to determine your optimal starting point, which may vary based on factors including your current weight, metabolic health, medication history, and any previous experience with GLP-1 medications. Some patients with heightened sensitivity benefit from even lower initial doses under medical supervision.

Starting low serves a critical purpose: it allows your clinical team to establish a baseline for how your individual body responds to semaglutide. This personalized approach means you're not receiving a one-size-fits-all dose that could cause unnecessary discomfort or that might be insufficient for your needs.

The Importance of Gradual Dose Escalation for Safety and Results

Your body requires time to acclimate to how semaglutide affects your digestive system, appetite signals, and metabolism. Rushing to higher doses increases the risk of nausea, constipation, and other gastrointestinal effects that might otherwise be avoided through slower titration, making the overall treatment experience more tolerable.

Gradual escalation also allows your clinical team to identify the minimum effective dose for your specific weight loss goals—the point where you experience meaningful appetite reduction and weight loss without unnecessary side effects. This precision approach aligns with PlexusDx's commitment to personalized medicine rather than population-average dosing.

Research from STEP trials demonstrates that weight loss improvement continues as doses increase, but the relationship is not linear. Many patients achieve excellent results at moderate doses (0.5-1.0 mg weekly) without advancing to maximum doses, reducing both cost and potential side effect burden.

Typical Semaglutide Dose Escalation Schedule

Most patients following PlexusDx protocols begin at 0.25 mg weekly and increase by 0.25 mg every four weeks, assuming good tolerance and physician approval. This standard titration schedule takes 16 weeks to reach the 1.0 mg maintenance dose, allowing your body's hunger and fullness systems to adapt progressively.

A typical escalation timeline follows this pattern: Week 1-4 at 0.25 mg, Week 5-8 at 0.5 mg, Week 9-12 at 0.75 mg, and Week 13+ at 1.0 mg weekly. Some individuals who experience mild nausea or digestive changes may extend any step by an additional two to four weeks before increasing further.

Maximum therapeutic doses for weight management reach 2.4 mg weekly, though most patients achieve substantial weight loss results at 1.0-1.5 mg weekly. Your PlexusDx physician will never recommend dose acceleration beyond your tolerance level, prioritizing long-term adherence and safety over rapid dosing increases.

What to Expect During Your Semaglutide Journey with PlexusDx

During your first week at 0.25 mg, you may notice subtle shifts in how you experience hunger—foods that previously seemed appealing might lose their attraction, and you may feel satisfied with smaller meal portions. These early signals indicate that semaglutide is engaging with your appetite regulation systems appropriately.

As your dose increases over weeks and months, most patients experience progressive weight loss averaging 1-2 pounds per week during the initial months, with cumulative losses of 15-22 pounds over the first three months. Individual results vary based on starting weight, metabolic factors, and adherence to lifestyle modifications alongside medication.

PlexusDx provides clinical monitoring throughout your therapy, with check-in appointments or virtual consultations to assess your response, review side effects, adjust doses if needed, and discuss nutrition and activity strategies that amplify your medication's effectiveness. This comprehensive support distinguishes personalized compounded therapy from unmonitored medication-only approaches.

Managing Side Effects and Optimizing Your Experience

Nausea represents the most commonly reported early side effect, typically appearing in the first 1-2 weeks and usually resolving within days to a few weeks as your body adapts. This effect often decreases with slower dose escalation, smaller meals, avoiding fatty or sugary foods, and staying well hydrated throughout the day.

Constipation occurs in some patients due to reduced food intake and semaglutide's effects on gastric motility. Preventive measures include increasing fiber intake gradually (rather than suddenly), consuming adequate water, maintaining regular physical activity, and discussing stool softeners with your PlexusDx physician if symptoms persist.

Less common side effects include mild fatigue, taste changes, or temporary appetite loss that interferes with nutrition. Your clinical team monitors these effects and can adjust your dose, modify your escalation schedule, or recommend specific dietary changes to maintain adequate protein and nutrient intake while using semaglutide.

Frequently Asked Questions About Starting Your Journey: What’s the Lowest Dose of Semaglutide?

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.